
Overview
Dr. Stapleton is the division chief of oncology and director of pediatric neuro-oncology at Johns Hopkins All Children’s Hospital. Dr. Stapleton joined the hospital in 2007. She has formal training in pediatric neuro-oncology. She received the Armstrong Award for Quality and Patient Safety for Johns Hopkins All Children's in the 2024 Johns Hopkins Medicine Clinical Awards. Dr. Stapleton is on the Pediatric Palliative Care Team at Johns Hopkins All Children’s, and she specializes in symptom control and end of life care. She has been awarded numerous grants for phase I studies for patients with brain and spinal cord tumors as well as clinical research in pediatric palliative care. Dr. Stapleton’s research experience includes investigator-initiated and multi-center research projects. Dr. Stapleton is an associate professor of pediatrics at the University of South Florida and an assistant professor in the department of pediatrics at Johns Hopkins University. Dr. Stapleton completed her medical training at St. Louis University School of Medicine, residency training at Lackland Air Force Base in Texas and fellowship training at Baylor College of Medicine/Texas Children’s Hospital. Dr. Stapleton also served 13 years in the United States Air Force. Dr. Stapleton is a member of the American Board of Pediatrics, the Children’s Oncology Group, the Society of Neuro-Oncology, American Society of Pediatric Hematology/Oncology, and America Academy of Hospice and Palliative Medicine.
Dr. Stapleton is highly rated in 11 conditions, according to our data. Her top areas of expertise are Medulloblastoma, Embryonal Tumor with Multilayered Rosettes, Glioma, Histiocytosis, and Bone Marrow Aspiration.
Her clinical research consists of co-authoring 27 peer reviewed articles and participating in 22 clinical trials. MediFind looks at clinical research from the past 15 years.
Residency
Specialties
Licenses
Board Certifications
Fellowships
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- EPO
- HMO
Locations
Suite 320, Saint Petersburg, FL 33701
12220 Bruce B Downs Boulevard, Tampa, FL 33612
Additional Areas of Focus
Dr. Stapleton has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
22 Clinical Trials
Johns Hopkins All Children's Outpatient Care, St. Petersburg
Dr. Vlachos is the chief of hematology in the Johns Hopkins All Children’s Hospital Cancer & Blood Disorders Institute in St. Petersburg, Florida, and professor of pediatrics (PAR) in the Johns Hopkins University School of Medicine. She joined the hospital staff in 2024. She was previously professor of pediatrics at Zucker School of Medicine at Hofstra/Northwell and attending physician in hematology/oncology at Cohen Children’s Medical Center/Northwell Health, where she was head of the Bone Marrow Failure Program and head of the pediatric hematology/oncology trials office. Dr. Vlachos is internationally known for clinical care and expertise in bone marrow failure syndromes and her transformational research in Diamond Blackfan anemia (DBA) syndrome, a rare inherited bone marrow failure syndrome. Dr. Vlachos is the founder and has directed the Diamond Blackfan Anemia Registry (DBAR) of North America since its inception in 1991. She is the principal investigator and co-investigator on multiple grants funded by the National Institute of Health and the Centers for Disease Control and Prevention. She has published numerous articles on her research findings and has been invited to author papers and book chapters on bone marrow failure syndromes and DBA. Dr. Vlachos is a member of the Medical and Scientific Advisory Board for the Shwachman-Diamond Syndrome Registry, is a member of the Scientific Advisory Board for the Diamond Blackfan Anemia Foundation and holds a position on the Scientific Program Committee for Bone Marrow Failure of the American Society of Hematology. She earned her medical degree from New York Medical College in Valhalla, New York. She completed her residency in pediatrics at North Shore University Hospital in Manhasset, New York. She then completed a clinical fellowship in bone marrow transplantation at North Shore University Hospital, followed by a fellowship in pediatric hematology-oncology and bone marrow transplantation at Mount Sinai Medical Center in New York. Videos Bone Marrow Failure Syndrome Expert Dr. Adrianna Vlachos at Johns Hopkins All Children’s. Dr. Vlachos is highly rated in 15 conditions, according to our data. Her top areas of expertise are Aase Syndrome, Pure Red Cell Aplasia, Aplastic Anemia, and Transient Erythroblastopenia of Childhood.
Johns Hopkins All Children's Outpatient Care, St. Petersburg
Dr. Metts specializes in pediatric hematology/oncology in the Johns Hopkins All Children's Cancer & Blood Disorders Institute. He sees patients on our main campus in St. Petersburg and at the Johns Hopkins All Children’s Outpatient Care Center in Tampa. He joined the hospital in 2016. He received his medical degree from the University of South Carolina School of Medicine and completed an internship and residency in pediatrics at Johns Hopkins All Children’s Hospital through the University of South Florida Morsani School of Medicine. Dr. Metts then trained at Emory University School of Medicine as a pediatric hematology/oncology fellow. His clinical interests include sarcomas, rare solid tumors, and Phase 1 and Phase 2 trials for pediatric solid tumors. Dr. Metts is highly rated in 7 conditions, according to our data. His top areas of expertise are Osteosarcoma, Ewing Sarcoma, Rhabdomyosarcoma, and Adult Soft Tissue Sarcoma.
Johns Hopkins All Children's Outpatient Care, St. Petersburg
Neil Goldenberg is a Pediatric Hematologist Oncology provider in Saint Petersburg, Florida. Dr. Goldenberg is highly rated in 3 conditions, according to our data. His top areas of expertise are Venous Thromboembolism (VTE), Mesenteric Venous Thrombosis, Blood Clots, Thrombectomy, and Gastrostomy.
Frequently Asked Questions about Dr. Stacie L. Stapleton
How do I make an appointment with Dr. Stacie L. Stapleton?
You can book an appointment with Dr. Stacie L. Stapleton by calling their office at 727-767-4176. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Stacie L. Stapleton a top-rated expert for Medulloblastoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Stacie L. Stapleton is classified as an Distinguished expert for Medulloblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Stacie L. Stapleton specialize in?
While Dr. Stacie L. Stapleton is a Pediatrics, they have specific expertise in Medulloblastoma, Embryonal Tumor with Multilayered Rosettes, and Glioma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatrics.
Does Dr. Stacie L. Stapleton participate in research or clinical trials?
Yes. Dr. Stacie L. Stapleton has published 27 articles and abstracts on conditions like Medulloblastoma. You can view a list of Dr. Stacie L. Stapleton's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Stacie L. Stapleton accept my insurance?
Dr. Stacie L. Stapleton accepts most major insurance plans, including Aetna and AvMed. We recommend calling the office directly at 727-767-4176 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- MedulloblastomaDr. Stapleton isDistinguished. Learn about Medulloblastoma.
- Advanced
- Denys-Drash Syndrome (DDS)Dr. Stapleton isAdvanced. Learn about Denys-Drash Syndrome (DDS).
- Embryonal Tumor with Multilayered Rosettes
- Ewing SarcomaDr. Stapleton isAdvanced. Learn about Ewing Sarcoma.
- GliomaDr. Stapleton isAdvanced. Learn about Glioma.
- HepatoblastomaDr. Stapleton isAdvanced. Learn about Hepatoblastoma.
- HistiocytosisDr. Stapleton isAdvanced. Learn about Histiocytosis.
- Experienced
- Adult Soft Tissue SarcomaDr. Stapleton isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Bone Marrow AspirationDr. Stapleton isExperienced. Learn about Bone Marrow Aspiration.
- NeuroblastomaDr. Stapleton isExperienced. Learn about Neuroblastoma.
- NeurofibromatosisDr. Stapleton isExperienced. Learn about Neurofibromatosis.
- Neurofibromatosis Type 1 (NF1)Dr. Stapleton isExperienced. Learn about Neurofibromatosis Type 1 (NF1).
- OsteosarcomaDr. Stapleton isExperienced. Learn about Osteosarcoma.


